Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Pedal oedema, the abnormal swelling of feet and ankles, signals underlying conditions like heart failure, liver cirrhosis, kidney disorders, or venous issues. Fluid accumulation occurs due to ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

In our study, we identify a regulatory pathway by which release of the neurotransmitter acetylcholine by B cells suppresses TNF production by lung interstitial macrophages early in influenza virus ...

Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor airflow, ...

If you have trouble breathing, your doctor may recommend a few tests to figure out what’s causing it. Some measure how much air you breathe in or out or how much oxygen is going from your lungs to the ...